πŸ‡ΊπŸ‡Έ FDA
Patent

US 11885806

Method for depleting malignant T-cells

granted A61KA61K2039/515A61K40/11

Quick answer

US patent 11885806 (Method for depleting malignant T-cells) held by AUTOLUS LIMITED expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AUTOLUS LIMITED
Grant date
Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/515, A61K40/11, A61K40/31, A61K40/421